(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

ILIAS Biologics was Invited to a Domestic Live Broadcast, 'Bio-weekly', by 'YTN Science Today'

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 20-09-04 13:10
  • 조회 : 216회

본문


5 Aug 2020

Dr. Chulhee Choi, CEO of ILIAS Biologics, was invited to a domestic live broadcast, 'Bio-weekly', by 'YTN Science Today'


23ba90be156c53891115e00d138aaab0_1599193106_0544.jpg 

Bio-Weekly is a domestic live broadcast managed by YTN Science Today, where they discuss weekly highlights or issues in the bio-industry field. The show started in June 2020 and has been featuring the impact of COVID-19 as well as hosting various biopharma companies in South Korea. In the 10th episode, ILIAS Biologics was invited to share basic information about exosomes, the outlook of exosome-based therapeutics as a novel drug delivery system, and some of the business highlights of ILIAS. We could realize the increased public interest of exosomes as ILIAS was invited to the 10th episode of the show that encompasses all major issues in the bio-industry. It was truly meaningful to us that we got to share the information with audiences and was our privilege to have this opportunity to represent exosome-based therapeutics as the leading company in the field. Again, we are very thankful to everyone who helped us and participated in the show.

 

Website (Click, Korean)

Youtube (Click, Korean) 

 

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기